KRISTINA ROGERS: Open Payments
NPI 1801394101 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 99 payments from 18 companies in 2025. Trend: 2023 $1,901 · 2024 $2,331 · 2025 $1,863
Food & beverage: $1,779Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $547 |
| Janssen Biotech, Inc. | 9 | $250 |
| PFIZER INC. | 11 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $154 |
| Aimmune Therapeutics, Inc. | 4 | $100 |
| Gilead Sciences, Inc. | 5 | $99 |
| Abbott Laboratories | 1 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| GENZYME CORPORATION | 2 | $39 |
Products named: RINVOQ, TREMFYA, ENTYVIO, XIFAXAN, SKYRIZI, VELSIPITY, LINZESS, ZENPEP.
Industry payments across OK — which companies pay providers there.
